| Detected | Trial | Change |
|---|---|---|
| 2026-05-14 | NCT06499285 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk… |
Trial sites expanded: 155 -> 179 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-03 | NCT07623161 A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07422480 | A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low… | Myelodysplastic Syndrome | Recruiting |
| NCT06499285 | A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk… | Myelodysplastic Syndromes | Recruiting |
| NCT07623161 | A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are… | Myelofibrosis | Not Yet Recruiting |
| Phase 2 | |||
| NCT05037760 | A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis | Myelofibrosis | Recruiting |
| NCT04419649 | A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk… | Myelodysplastic Syndromes | Recruiting |
| NCT07319845 | A Study of TAK-226 for Transfusion-Dependent Anemia in Japanese Patients With Lower-Risk… | Myelodysplastic Syndromes | Not Yet Recruiting |